Swensen’s
-
Franchise India Bureau Apr 05 2018 - 3 min readTorrent Pharmaceuticals backed off from a deal with Sanofi’s European generic business, which was valued at $2 billion (Rs 160 billion), sources said, adding Torrent felt the deal value was high. Torrent was in the race for Sanofi’s generic drugs unit, Zentiva, and was preparing a binding bid of $2 billion. ...
-
Franchise India Bureau Feb 21 2018 - 1 min readAurobindo Pharma is eyeing US $1.7-billion privately held European Business in the form of a Canadian Drug Maker Apotex. Known for its high profile litigations in the US against MNC pharma players, Apotex has put on the block its European operations as part of a wider consolidation effort According to the ...